Electromagnetic field‑inducible gene switch: a non‑invasive platform for remote spatiotemporal gene control
In a recent study published in Cell , Kim et al. present a remotely controlled, electromagnetic field (EMF)-inducible gene switch, termed the Ei switch, that enables precise spatiotemporal activation of transgene expression in vivo without pharmacological agents or invasive procedures. 1 By engineering a 450-bp EMF-responsive DNA element (Ei) derived from the leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) promoter, the authors established a transcriptional platform selectively responsive to extremely low-frequency EMF (EL-EMF) under the tested conditions, offering a non-invasive and reversible mode of gene regulation with the potential to address key limitations of optogenetics (limited tissue penetration) and reduce reliance on pharmacological inducers such as tetracycline-responsive systems. 1 , 2 , 3
Authors
- Hae-Jun Yang
- Young‐Ho Park (ORCID: https://orcid.org/0000-0001-5405-1231)
- MinYoung Kim
Institutions
- CHA University Bundang Medical Center (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Korea University of Science and Technology (KR)
Publication Details
- Journal
- Signal Transduction and Targeted Therapy
- Published
- 2026-08-20
- DOI
- https://doi.org/10.1038/s41392-026-02898-9
- Primary Topic
- Electromagnetic Fields and Biological Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- Korea Health Industry Development Institute
- Korea Research Institute of Bioscience and Biotechnology
- National Research Foundation of Korea
- National Research Council of Science and Technology
- Ministry of Science and ICT, South Korea